rs9381994

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138694.4(PKHD1):​c.12143A>G​(p.Gln4048Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.554 in 1,613,906 control chromosomes in the GnomAD database, including 248,948 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 21709 hom., cov: 35)
Exomes 𝑓: 0.56 ( 227239 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.422

Publications

38 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0750294E-5).
BP6
Variant 6-51619163-T-C is Benign according to our data. Variant chr6-51619163-T-C is described in ClinVar as Benign. ClinVar VariationId is 96376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.624 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.12143A>G p.Gln4048Arg missense_variant Exon 67 of 67 ENST00000371117.8 NP_619639.3 P08F94-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.12143A>G p.Gln4048Arg missense_variant Exon 67 of 67 1 NM_138694.4 ENSP00000360158.3 P08F94-1
ENSG00000228689ENST00000454361.1 linkn.81-3192T>C intron_variant Intron 1 of 1 3
ENSG00000228689ENST00000589278.6 linkn.811-3197T>C intron_variant Intron 2 of 2 5
ENSG00000228689ENST00000650088.1 linkn.222-3192T>C intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.533
AC:
81013
AN:
152104
Hom.:
21711
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.479
Gnomad AMI
AF:
0.397
Gnomad AMR
AF:
0.580
Gnomad ASJ
AF:
0.489
Gnomad EAS
AF:
0.586
Gnomad SAS
AF:
0.643
Gnomad FIN
AF:
0.510
Gnomad MID
AF:
0.570
Gnomad NFE
AF:
0.550
Gnomad OTH
AF:
0.524
GnomAD2 exomes
AF:
0.566
AC:
142135
AN:
250914
AF XY:
0.566
show subpopulations
Gnomad AFR exome
AF:
0.479
Gnomad AMR exome
AF:
0.650
Gnomad ASJ exome
AF:
0.499
Gnomad EAS exome
AF:
0.585
Gnomad FIN exome
AF:
0.526
Gnomad NFE exome
AF:
0.548
Gnomad OTH exome
AF:
0.554
GnomAD4 exome
AF:
0.556
AC:
813130
AN:
1461684
Hom.:
227239
Cov.:
52
AF XY:
0.558
AC XY:
406037
AN XY:
727146
show subpopulations
African (AFR)
AF:
0.475
AC:
15907
AN:
33474
American (AMR)
AF:
0.637
AC:
28473
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.492
AC:
12850
AN:
26136
East Asian (EAS)
AF:
0.591
AC:
23451
AN:
39696
South Asian (SAS)
AF:
0.626
AC:
53966
AN:
86256
European-Finnish (FIN)
AF:
0.531
AC:
28346
AN:
53402
Middle Eastern (MID)
AF:
0.573
AC:
3304
AN:
5762
European-Non Finnish (NFE)
AF:
0.552
AC:
613819
AN:
1111858
Other (OTH)
AF:
0.547
AC:
33014
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
22415
44829
67244
89658
112073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17326
34652
51978
69304
86630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.532
AC:
81035
AN:
152222
Hom.:
21709
Cov.:
35
AF XY:
0.532
AC XY:
39565
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.478
AC:
19869
AN:
41532
American (AMR)
AF:
0.580
AC:
8875
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.489
AC:
1696
AN:
3468
East Asian (EAS)
AF:
0.587
AC:
3033
AN:
5170
South Asian (SAS)
AF:
0.643
AC:
3100
AN:
4822
European-Finnish (FIN)
AF:
0.510
AC:
5397
AN:
10592
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.550
AC:
37434
AN:
68010
Other (OTH)
AF:
0.522
AC:
1104
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2022
4045
6067
8090
10112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.545
Hom.:
100866
Bravo
AF:
0.536
TwinsUK
AF:
0.549
AC:
2035
ALSPAC
AF:
0.551
AC:
2125
ESP6500AA
AF:
0.481
AC:
2120
ESP6500EA
AF:
0.549
AC:
4719
ExAC
AF:
0.563
AC:
68311
Asia WGS
AF:
0.597
AC:
2076
AN:
3476
EpiCase
AF:
0.549
EpiControl
AF:
0.554

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive polycystic kidney disease Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 11, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease 4 Benign:3
Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 25, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 27, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Thec.12143A>G, p.Gln4048Arg variant was identified in 56.3% of 68262 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015). -

not provided Benign:1
Aug 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28509106) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.28
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.000011
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.5
L
PhyloP100
0.42
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.21
Sift
Benign
0.52
T
Sift4G
Benign
0.25
T
Polyphen
0.031
B
Vest4
0.021
MPC
0.064
ClinPred
0.010
T
GERP RS
4.0
Varity_R
0.046
gMVP
0.16
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9381994; hg19: chr6-51483961; COSMIC: COSV64381840; COSMIC: COSV64381840; API